Lactoferrin in the treatment of diabetes mellitus
AssigneeAgennix, Inc.
InventorsJose Engelmayer, Atul Varadhachary
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of using a composition of lactoferrin for the treatment of diabetes mellitus as manifested by a reduction in the levels of serum glucose, blood pressure, obesity, or glycosylated hemoglobin (HbA1c).
Claims27
1-41. (canceled)
A method of modulating diabetes mellitus comprising the step of administering to a subject an effective amount of a lactoferrin composition, wherein the amount of said lactoferrin composition modulates at least one symptom of diabetes mellitus and wherein the lactoferrin composition is administered in combination with an antidiabetic drug.
A method of treating diabetes mellitus comprising administering to a subject an effective amount of a composition having an N-terminal lactoferrin variant, wherein the amount of said lactoferrin composition decreases blood levels of glucose and insulin thereby treating diabetes mellitus and wherein the lactoferrin composition is administered in combination with an antidiabetic drug.
A method of treating hyperglycemia in a subject comprising administering to the subject an effective amount a composition having an N-terminal lactoferrin variant, wherein the amount of said lactoferrin composition decreases blood glucose and wherein the lactoferrin composition is administered in combination with an antidiabetic drug.
Dependencies are inferred from the claim text.